Zu dieser Karteikarte gibt es einen kompletten Satz an Karteikarten. Kostenlos!

PDX tumor models, or Patient-Derived Xenograft tumor models, are a cutting-edge tool in cancer research and drug development, offering a more accurate representation of human tumor biology than traditional cell line-derived models. These models are created by implanting cancerous tissue directly from a patient into immunodeficient mice, allowing the tumor to grow in a living organism while maintaining its original characteristics, such as histological architecture, genetic profile, and tumor microenvironment.

The use of PDX tumor models in preclinical research provides several advantages. They enable researchers to study tumor behavior and response to therapies in a complex biological system that closely mimics human cancer. This allows for the evaluation of the efficacy and safety of new anticancer drugs and therapeutic strategies before clinical trials. Moreover, PDX models are invaluable in the development of personalized medicine approaches, as they can be used to test multiple treatments on a patient’s specific tumor, identifying the most effective therapy for that individual.

As more is understood about tumor heterogeneity and resistance mechanisms, PDX tumor models continue to play a crucial role in unraveling these complexities and accelerating the translation of research findings into clinical applications. By providing a more reliable and predictive platform for cancer therapy testing, PDX models hold the potential to improve treatment outcomes and advance the field of oncology.